Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EU Allows Firms More Time To Make Nitrosamine-Related Manufacturing Changes
Deadline Extended To Enable Companies To Perform A Thorough Investigation
Aug 16 2022
•
By
Vibha Sharma
Nitrosamine impurities have been found in marketed medicines in the recent past • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography